Cytomegalovirus (CMV) is the single most important infectious agent affecting recipients of
organ transplants, with at least two-thirds of these patients having CMV infection 1–4 months …

CD8+ T cells are the main effector cells for the immune control of cytomegaloviruses. To
subvert this control, human and mouse cytomegaloviruses each encode a set of immune …

We have established a murine model system for exploring the ability of a CD4 subset-
deficient host to cope with cytomegalovirus infection, and reported three findings. First, an …

We have shown in a murine model system for acute, lethal cytomegalovirus (CMV) disease
in the immunocompromised natural host that control of virus multiplication in tissues …

Interstitial pneumonia associated with viral replication in lung tissue was observed after
cytomegalovirus infection of total-body gamma-irradiated mice, whereas in …

Primary Cytomegalovirus (CMV) infection and reactivation of persistent CMV are associated
with significant morbidity and mortality in immuno‐compromised individuals. Although …

Peptides that are antigenic for T lymphocytes are ligands for two receptors, the class I or II
glycoproteins that are encoded by genes in the major histocompatibility complex, and the …

Although the relative contribution of different immune effector functions to clearing tissues of
cytomegalovirus is controversial, the contribution of CD8+ T lymphocytes has generally …

Cytomegalovirus (CMV), similar to other members of the Herpesviridae family, can establish
both persistent and latent infections. Each of the CMVs that are found in many animal …

Interstitial cytomegalovirus (CMV) pneumonia is a clinically relevant complication in
recipients of bone marrow transplantation (BMT). Recent data for a model of experimental …